These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26290426)

  • 1. Increased prevalence of influenza B/Victoria lineage viruses during early stages of the 2015 influenza season in New South Wales, Australia: implications for vaccination and planning.
    Jennings Z; Carter I; McPhie K; Kok J; Dwyer DE
    Euro Surveill; 2015 Aug; 20(31):. PubMed ID: 26290426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996-2012: Implications for vaccine composition strategy.
    Paiva TM; Benega MA; Silva DB; Santos KC; Cruz AS; Hortenci MF; Barbieri MT; Monteiro MM; Barbosa HA; Carvalhanas TR
    J Med Virol; 2013 Nov; 85(11):1983-9. PubMed ID: 23926069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.
    Broberg E; Melidou A; Prosenc K; Bragstad K; Hungnes O;
    Euro Surveill; 2016; 21(13):. PubMed ID: 27074657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia.
    Jamotte A; Chong CF; Manton A; Macabeo B; Toumi M
    BMC Public Health; 2016 Jul; 16():630. PubMed ID: 27449665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Season Pediatric Influenza B/Victoria Virus Infections Associated with a Recently Emerged Virus Subclade - Louisiana, 2019.
    Owusu D; Hand J; Tenforde MW; Feldstein LR; DaSilva J; Barnes J; Lee G; Tran J; Sokol T; Fry AM; Brammer L; Rolfes MA
    MMWR Morb Mortal Wkly Rep; 2020 Jan; 69(2):40-43. PubMed ID: 31945035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
    Noh JY; Choi WS; Song JY; Lee HS; Lim S; Lee J; Seo YB; Lee JS; Wie SH; Jeong HW; Heo JY; Kim YK; Park KH; Kim SW; Lee SH; Lee JH; Kim DH; Woo SI; Lim CS; Cho KS; Cheong HJ; Kim WJ
    Vaccine; 2018 Aug; 36(35):5304-5308. PubMed ID: 30057284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.
    Heikkinen T; Ikonen N; Ziegler T
    Clin Infect Dis; 2014 Dec; 59(11):1519-24. PubMed ID: 25139969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of the 2012 influenza season in Victoria, Australia.
    Fielding J; Grant K; Franklin L; Sullivan S; Papadakis G; Kelly H; Cheng A
    Western Pac Surveill Response J; 2013; 4(3):42-50. PubMed ID: 24319614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological study of influenza B in Shanghai during the 2009-2014 seasons: implications for influenza vaccination strategy.
    Zhao B; Qin S; Teng Z; Chen J; Yu X; Gao Y; Shen J; Cui X; Zeng M; Zhang X
    Clin Microbiol Infect; 2015 Jul; 21(7):694-700. PubMed ID: 25882368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season.
    Barr IG; Vijaykrishna D; Sullivan SG
    Euro Surveill; 2016; 21(4):. PubMed ID: 26848118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016.
    Havlickova M; Druelles S; Jirincova H; Limberkova R; Nagy A; Rasuli A; Kyncl J
    BMC Infect Dis; 2019 Feb; 19(1):160. PubMed ID: 30764763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usage of quadrivalent influenza vaccine among children in the United States, 2013-14.
    Rodgers L; Pabst LJ; Zhu L; Chaves SS
    Vaccine; 2015 Nov; 33(48):6517-8. PubMed ID: 26296494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study.
    Savulescu C; Jiménez-Jorge S; de Mateo S; Ledesma J; Pozo F; Casas I; Larrauri A;
    Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of influenza B in Australia: 2001-2014 influenza seasons.
    Moa AM; Muscatello DJ; Turner RM; MacIntyre CR
    Influenza Other Respir Viruses; 2017 Mar; 11(2):102-109. PubMed ID: 27650482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.